Go to the list of all blogs
Niko Sharks's Avatar
published in Blogs
Feb 28, 2025

Heating Up: Heater Industry Stocks( $AAON, $AOS, $FIX...) Soar with Average Gains

In the last week, the heater industry has shown significant financial warmth, with stocks posting an average gain of 10.75%. This group, comprising manufacturers of heating appliances and systems for both residential and commercial buildings, has demonstrated a robust performance in the stock market.

🌐Tickers in Industry - $AAON, $AOS, $FIX, $LII, $WSO

Trend Trader, Popular Stocks: Price Action Trading Strategy (TA&FA)

The Composition of the Heater Industry

The heater industry is an amalgam of companies specializing in the production of heating appliances, systems, and accompanying air conditioning and refrigeration equipment. Notable names in this sector include Watsco Inc., AAON Inc., and Lennox International. These companies represent a broad range of operations within the industry, catering to a diverse clientele seeking comfort in varying climates.

Market Capitalization

When it comes to market size, the heater industry is substantial, with an average market capitalization of $9.6 billion. The values of individual companies within this theme range from $4.4 billion to a whopping $13.8 billion, with Watsco Inc. boasting the largest valuation. In contrast, AAON Inc. marks the lower end of the spectrum, reflecting a variety of investment scales within the theme.

Price Movements: Peaks and Valleys

The upward trend in the heater sector is highlighted by an impressive average weekly price growth of 10.74%. This short-term growth overshadows the monthly and quarterly averages, which stand at 3.4% and 9.8%, respectively. FIX leads the surge with a remarkable 17.45% climb, while Watsco Inc. had the least gains, albeit a marginal dip of 0.5%.

Noteworthy Performers

In recent trading updates, AO Smith has consistently been a star performer, showcasing notable weekly jumps of over 5% on two separate occasions and emerging as a weekly top gainer. However, it's worth mentioning that AO Smith had faced some headwinds earlier in the year with a significant weekly drop, indicating a market that rewards vigilant investors.

Trading Volume Insight

The trading volume within the heater industry has been heating up as well. An average weekly volume growth of 16.04% speaks volumes about the investor interest in these stocks. Not to be overshadowed, the monthly and quarterly volume growths have also shown impressive figures, further solidifying the sector's robust activity.

Record-breaking daily volume growths for AAON and Watsco stocks earlier in the year indicate significant investor attention, highlighting specific days where trading activity reached peaks that far exceeded the 65-Day Volume Moving Average.

Fundamental Analysis

Investors who rely on fundamental analysis to guide their investment decisions would be interested to note that the ratings within this industry vary, providing ample opportunities for diverse investment strategies.

The heater industry is currently experiencing a period of strong financial performance, with the average stock within this theme enjoying substantial gains. As the industry covers essential household and building amenities, its stocks reflect the demand for comfortable living and working environments. The significant market capitalization, vigorous price growth, and robust trading volumes all underscore a theme that is currently running hot on the market.

FIX : Comfort Systems USA, Inc. (FIX) presented a positive turn in its Momentum Indicator, crossing the pivotal 0 mark on October 27, 2023. This shift suggests a potential trend reversal to the upside. Market participants eyeing this development may view it as an opportune moment for stock purchases or call option strategies. Tickeron's A.I.dvisor, having analyzed 92 analogous events, found that FIX's stock price ascended in 73 cases thereafter, establishing a strong 79% likelihood of continued gains in the stock's performance post-indicator shift.

LII : Lennox International Inc. (LII) exhibited a bullish signal as its MACD Histogram crossed above the signal line on October 31, 2023. Historical data indicates that following such crossovers, LII's shares advanced in 37 out of 50 occurrences, translating to a 74% chance of continued upward momentum over the next month. Investors may see this as a favorable sign for the stock's near-term trajectory.

WSO : On October 24, 2023, Watsco Inc.’s (WSO) Relative Strength Index (RSI) rallied past the oversold threshold, signaling a potential reversal from its recent selloff. Historical patterns analyzed by A.I.dvisor show that in 12 out of 17 comparable scenarios, such an RSI shift preceded a rise in WSO's stock price, suggesting a 71% probability of an upward trend. Investors may consider this a cue for prospective buying or option strategies.

Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.